TP53 and colorectal carcinoma: Co-expression and pathway analysis of novel CRC susceptibility genes showed that over half (13/23) are involved in the regulation of p53 activity, 15 in cell cycle events (mitosis and apoptosis), and 11 in modifying signaling by interleukins (Supplementary Table 7).